Message Board

Respected readers, authors and reviewers, you can add comments to this page on any questions about the contribution, review,        editing and publication of this journal. We will give you an answer as soon as possible. Thank you for your support!

Name
E-mail
Phone
Title
Content
Verification Code

Ma Li-ye, . A clinical study of tiopconin for infection in treating jaundice viral hepatitis[J]. Journal of Pharmaceutical Practice and Service, 2002, (4): 199-200.
Citation: Ma Li-ye, . A clinical study of tiopconin for infection in treating jaundice viral hepatitis[J]. Journal of Pharmaceutical Practice and Service, 2002, (4): 199-200.

A clinical study of tiopconin for infection in treating jaundice viral hepatitis

  • Received Date: 2002-03-19
  • OBJECTIVE To search for the efficacy and side effects of tiopconin for injection in treating jaundice viral hepatitis. METHODS 114 patients were randmoly divided into 2 groups, 58 cases as a treatment group were administed tiopconin for injection 0.2g in 5% glucose solution 250ml by intravenous infusion, 56 cases as a comparison group received conventional drugs. RESULTS After the course of treatment, the symptom and sign of the treatment group was better than the comparison group (P <0.05). Tiopconin for injection can improve the reproduction of the toxin to the liver. Side effects had not been found. CONCLUSION Tiopconin for injection is an effective agent for treatment of jaundice viral hepatitis. So it is worth spreading.
  • 加载中
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Article Metrics

Article views(1756) PDF downloads(407) Cited by()

Related
Proportional views

A clinical study of tiopconin for infection in treating jaundice viral hepatitis

Abstract: OBJECTIVE To search for the efficacy and side effects of tiopconin for injection in treating jaundice viral hepatitis. METHODS 114 patients were randmoly divided into 2 groups, 58 cases as a treatment group were administed tiopconin for injection 0.2g in 5% glucose solution 250ml by intravenous infusion, 56 cases as a comparison group received conventional drugs. RESULTS After the course of treatment, the symptom and sign of the treatment group was better than the comparison group (P <0.05). Tiopconin for injection can improve the reproduction of the toxin to the liver. Side effects had not been found. CONCLUSION Tiopconin for injection is an effective agent for treatment of jaundice viral hepatitis. So it is worth spreading.

Ma Li-ye, . A clinical study of tiopconin for infection in treating jaundice viral hepatitis[J]. Journal of Pharmaceutical Practice and Service, 2002, (4): 199-200.
Citation: Ma Li-ye, . A clinical study of tiopconin for infection in treating jaundice viral hepatitis[J]. Journal of Pharmaceutical Practice and Service, 2002, (4): 199-200.

Catalog

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return